Real-time enrollment status for this lung cancer clinical trial
Current Status
Terminated
Checked: March 2, 2026 at 11:52 AM UTC
| NCT Number | NCT05860296 |
| Recruiting Status | Terminated |
| Condition | Lung Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 92 participants |
| Active Locations | 7 sites in the US |
| Sponsor | SignalChem Lifesciences Corporation |
| Last Updated on CT.gov | December 18, 2025 (Dec 18, 2025) |
As of March 2, 2026: Clinical trial NCT05860296 is currently terminated participants. This clinical trial study for lung cancer is not currently accepting new participants at 7 locations across the United States. The study is sponsored by SignalChem Lifesciences Corporation. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05860296 is currently terminated. The study may resume recruiting in the future.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05860296 was last updated Dec 18, 2025 (December 18, 2025). HelloStudys verifies this status automatically.